Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Plos One|April 7, 2016
Incidence and Risk Factors for Severe Bacterial Infections in People Living with HIV. ANRS CO3 Aquitaine Cohort, 2000-2012Amandine Collin, Fabien Le Marec, Marie-Anne Vandenhende, et al.Infectious Diseases Now|July 20, 2025
Management of catheter-related septic thrombosisVictor Hémar, Hélène Chaussade, Claire Rivoisy, et al.Plos One|June 19, 2013
Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012Philippe Morlat, Alexandre Vivot, Marie-Anne Vandenhende, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 4, 2020
Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000-2018Eva Teruel, Marie-Anne Vandenhende, Didier Neau, et al.Plos One|January 30, 2014
Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failureMarie-Anne Vandenhende, Pantxika Bellecave, Patricia Recordon-Pinson, et al.Plos One|June 18, 2015
Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000Marie-Anne Vandenhende, Caroline Roussillon, Sandrine Henard, et al.The Journal of Antimicrobial Chemotherapy|November 22, 2020
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infectionEtienne Meriglier, Claire Rivoisy, Mojgan Hessamfar, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 4, 2010
CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007Mathias Bruyand, Marie-Anne Vandenhende, Guillaume Marcel, et al.AIDS (London, England)|November 7, 2015
Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patientsPierre Duffau, Linda Wittkop, Estibaliz Lazaro, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Severe Bacterial Non-AIDS Infections in Persons With Human Immunodeficiency Virus: The Epidemiology and Evolution of Antibiotic Resistance Over an 18-Year Period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine CohortPeggy Blanc, Fabrice Bonnet, Olivier Leleux, et al.Pageof 3